Attached files
file | filename |
---|---|
EX-99.1 - EX-99.1 - AdaptHealth Corp. | a18-7181_1ex99d1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): February 27, 2018 (February 21, 2018)
DFB Healthcare Acquisitions Corp.
(Exact Name of Registrant as Specified in Charter)
Delaware |
|
001-38399 |
|
82-3677704 |
780 Third Avenue |
|
10017 |
(212) 551-1600
(Registrants telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 8.01. Other Events.
On February 21, 2018, DFB Healthcare Acquisitions Corp. (the Company) completed its initial public offering (IPO) of 25,000,000 units (Units), each Unit consisting of one share of common stock, par value $0.0001 per share (Common Stock) and one-third of one warrant (Warrant), each whole Warrant exercisable to purchase one share of Common Stock, pursuant to the Companys registration statement on Form S-1, as amended (File No. 333-222376). The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $250,000,000.
As previously reported on a Current Report on Form 8-K of the Company, on February 21, 2018, simultaneously with the consummation of the IPO, the Company completed a private placement (the Private Placement) of an aggregate of 4,333,333 warrants (the Private Placement Warrants) at a price of $1.50 per Private Placement Warrant, generating total proceeds of $6,500,000.
A total of $250,000,000 of the net proceeds from the IPO and the Private Placement were deposited in a trust account established for the benefit of the Companys public stockholders. An audited balance sheet as of February 21, 2018 reflecting receipt of the proceeds upon consummation of the IPO and the Private Placement has been issued by the Company and is included as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. |
|
Description |
99.1 |
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
|
DFB HEALTHCARE ACQUISITIONS CORP. | ||
|
| ||
|
By: |
/s/ Richard Barasch | |
|
|
Name: |
Richard Barasch |
|
|
Title: |
Chief Executive Officer |
Date: February 27, 2018